Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Maraviroc
Medication labelSELZENTRY is indicated in combination with other antiretroviral agents for the treatment of only CCR5‑tropic human immunodeficiency virus…
Why this: Advisory · dailymed-prescription
SELZENTRY is indicated in combination with other antiretroviral agents for the treatment of only CCR5‑tropic human immunodeficiency virus type 1 (HIV‑1) infection in adult and pediatric patients weighing at least 2 kg. Limitations of Use •SELZENTRY is not recommended in patients with dual/mixed- or CXCR4-tropic HIV-1 [see Microbiology (12.4)].
- generic_name
- maraviroc
- product_names
- maraviroc
- ndc
- 49702-223, 49702-223-18, 49702-224, 49702-224-18, 49702-260, 49702-260-55
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en